Reducing the visual burden of glaucoma in asia: What we know and what we need to know

Journal of Glaucoma

Volumn 18, Issue 1, 2009, Pages 88-92

  Congdon, Nathan ^a,b,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Shantou University Medical College   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asia; Blindness prevention; Cataract; Epidemiology; Glaucoma; Rural health

Indexed keywords

ASIA; BLINDNESS; CLOSED ANGLE GLAUCOMA; DEVELOPING COUNTRY; HUMAN; KNOWLEDGE; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL RESEARCH; OPEN ANGLE GLAUCOMA; OPTIC NERVE LESION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ARTICLE; ATTITUDE TO HEALTH;

ASIA; BLINDNESS; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS;

EID: 63449132355     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e318182ee0b     Document Type: Review

References (92)

1. Hollows FC, Graham PA. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol. 1966;50:570-586.
2. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2632 adults, 1973 to 1975. Surv Ophthalmol. 1980;24(suppl):335-610.
3. Klein BE, Klein R, Linto KL, et al. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology. 1990;97:1428-1433.
4. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450-1460. Review.
5. Wensor MD, McCarty CA, Stanislavsky YL, et al. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology. 1998;105:733-739.
6. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998; 116:653-658.
7. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
8. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266:369-374.
9. Leske MC, Connell AM, Schachat AP, et al. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821-829.
10. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci. 1997;38:72-82.
11. Congdon N, West SK, Buhrmann RR, et al. Prevalence of the different types of age-related cataract in an African population. Invest Ophthalmol Vis Sci. 2001;42:2478-2482.
12. Foster PJ, Oen FT, Machin D, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol. 2000;118:1105-1111.
13. Xu L, Li J, Cui T, et al. Visual acuity in northern China in an urban and rural population: the Beijing Eye Study. Br J Ophthalmol. 2005;89:1089-1093.
14. West SK, Klein R, Rodriguez J, et al; Proyecto VER. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001;24:1204-1209.
15. Varma R, Ying-lai M, Klein R, et al; Los Angeles Latino Eye Study Group. Prevalence and risk indicators of visual impairment and blindness in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1132-1140.
16. West S. Epidemiology of cataract: accomplishments over 25 years and future directions. Ophthalmic Epidemiol. 2007;14: 173-178. Review.
17. Leske MC, Heijl A, Hyman L, et al; EMGT Group. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965-1972.
18. Klein R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol. 2007;14: 184-187. Review.
19. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
20. Ferris FL III, Podgor MJ, Davis MD. Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12. Ophthalmology. 1987;94:754-760.
21. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98(5 suppl):766-785.
22. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298:902-916. Review.
23. Macular Photocoagulation Study Group. Laser photocoagula-tion for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol. 1994; 112:500-509.
24. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. 2007;18:502-508. Review.
25. Lichter PR, Musch DC, Janz NK. The investigators' perspective on the Collaborative Initial Glaucoma Treatment Study (CIGTS). Arch Ophthalmol. 2008;126:122-124.
26. Leske MC, Heijl A, Hussein M, et al; Early Manifest Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
27. Beck AD; Advanced Glaucoma Intervention Study. Review of recent publications of the Advanced Glaucoma Intervention Study. Curr Opin Ophthalmol. 2003;14:83-85. Review.
28. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479-1496.
29. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
30. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844-851.
31. Resnikoff S, Pascoloni D, Mariotti SP, et al. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ. 2008;86:63-70.
32. Congdon NG, Rao SK, Zhao X, et al. Visual function and postoperative care after cataract surgery in rural China: Study Of Cataract Outcomes And Up-Take Of Services (SCOUTS) in the caring is hip project, Report 2. Arch Ophthalmol. 2007;125: 1546-1552.
33. He M, Chan V, Baruwa E, et al. Willingness to pay for cataract surgery in rural Southern China. Ophthalmology. 2007;114: 411-416.
34. Congdon N, Rao SK, Choi K, et al. Sources of patient knowledge and financing of cataract surgery in rural China: the Sanrao Study of Cataract Outcomes and Up-Take of Services (SCOUTS), Report 6. Br J Ophthalmol. 2008;92: 604-608.
35. Castanon Holguin AM, Congdon N, Patel N, et al. Factors associated with spectacle-wear compliance in school-aged Mexican children. Invest Ophthalmol Vis Sci. 2006;47:925-928.
36. Congdon N, Zheng MW, Sharma A, et al. Prevalence and determinants of spectacle non-wear among rural Chinese secondary school children: the Xichang Pediatric Refractive Error Study (X-PRES), Report 3. Arch Ophthalmol. In press.
37. Li LP, Song Y, Liu XJ, et al. Spectacle uptake among secondary school students with visually-significant refractive error in rural China: the Xichang Pediatric Refractive Error Study (X-PRES) Report 5. Invest Ophthalmol Vis Sci. 2008; 49:2895-2902.
38. Ramke J, du Toit R, Palagyi A, et al. Correction of refractive error and presbyopia in Timor-Leste. Br J Ophthalmol. 2007; 91:860-866.
39. Congdon N, Patel N, Esteso P, et al. The association between refractive cutoffs for spectacle provision and visual improvement among school-aged children in South Africa. Br J Ophthalmol. 2008;92:13-18.
40. Quigley HA, Park CK, Tracey PA, et al. Community screening for eye disease by laypersons: the Hoffberger program. Am J Ophthalmol. 2002;133:386-392.
41. Okeke CN, Friedman DS, Jampel HD, et al. Targeting relatives of patients with primary open angle glaucoma: the help the family glaucoma project. J Glaucoma. 2007;16: 549-555.
42. Saw SM, Foster PJ, Gazzard G, et al. Causes of blindness, low vision, and questionnaire-assessed poor visual function in Singaporean Chinese adults: the Tanjong Pagar Survey. Ophthalmology. 2004;111:1161-1168.
43. Dandona L, Dandona R, Srinivas M, et al. Blindness in the Indian state of Andhra Pradesh. Invest Ophthalmol Vis Sci. 2001; 42:908-916.
44. Thulasiraj RD, Nirmalan PK, Ramakrishnan R, et al. Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey. Ophthalmology. 2003;110:1491-1498.
45. Anderson DR; Normal Tension Glaucoma Study. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003;14:86-90. Review.
46. Glaucoma Laser Trial Research Group (GLT): 6. Treatment group differences in visual field changes. Am J Ophthalmol. 1995;120:10-22.
47. Gedde SJ, Herndon LW, Brandt JD, et al. Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol. 2007;143:23-31.
48. Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol. 2007;143:9-22.
49. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
50. Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem? Br J Ophthalmol. 2001;85:1277-1282. Review.
51. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262-267.
52. Fleck BW, Dhillon B, Khanna V, et al. A randomized, prospective comparison of Nd: YAG laser iridotomy and operative peripheral iridectomy in fellow eyes. Eye. 1991;5: 315-321.
53. Saunders DC. Acute closed-angle glaucoma and Nd-YAG laser iridotomy. Br J Ophthalmol. 1990;74:523-525.
54. Snow JT. Value of prophylactic peripheral iridectomy in the second eye in angle-closure glaucoma. Trans Ophthalmic Soc UK. 1977;97:189-191.
55. Fleck BW, Wright E, Fairley EA. A randomized prospective comparison of operative peripheral iridectomy and Nd: YAG laser iridotomy of acute angle closure glaucoma: 3-year visual acuity and intra-ocular pressure control outcome. Br J Ophthalmol. 1997;81:884-888.
56. Schwenn O, Sell F, Pfeiffer N, et al. Prophylactic Nd:YAG-laser iridotomy versus surgical iridectomy: a randomized, prospective study. Ger J Ophthalmol. 1995;4:374-379.
57. Buckley SA, Reeves B, Burdon M, et al. Acute angle-closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcome. Br J Ophthalmol. 1994;78: 529-533.
58. Aung LP, Aung T, Chew PT. Acute primary angle closure in an Asian population: long-term outcome of the fellow eyes after prophylactic laser PI. Ophthalmology. 2000;107: 2092-2096.
59. Wilensky JT, Kaufman PL, Frohlichstein D, et al. Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol. 1993; 115:338-346.
60. He M, Friedman DS, Ge J, et al. Laser peripheral iridotomy in primary angle-closure suspects: biometric and gonioscopic outcomes. Ophthalmology. 2007;114:494-500.
61. Hsiao CH, Hsu CT, Shen SC, et al. Mid-term follow-up of Nd:YAG laser iridotomy in Asian eyes. Ophthalmic Surg Lasers Imaging. 2003;34:291-298.
62. Krupin T, Stone RA, Cohen BH, et al. Acute intra-ocular pressue response to argon laser iridotomy. Ophthalmology. 1985;92:922-926.
63. Aung T, Ang LP, Chan SP, et al. Acute primary angle closure: long-term intra-ocular pressure outcome in Asia eyes. Am J Ophthalmol. 2001;131:7-12.
64. Playfair TJ, Watson PG. Management of acute primary angle-closure glaucoma: a long-term follow-up of the results of peripheral iridectomy used as an initial procedure. Br J ophthalmol. 1979;63:17-22.
65. Lim LS, Aung T, Husain R, et al. Acute primary angle closure: configuration of the drainage angle in the first year after laser peripheral iridotomy. Ophthalmology. 2004;111:1470-1474.
66. Rosman M, Aung T, Ang LP, et al. Chronic angle-closure with glaucomatous damage: long-term clinical course in a North American population and comparison with an Asian population. Ophthalmology. 2002;109:2227-2231.
67. Lam DS, Leung DY, Tham CC, et al. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. Ophthalmology. 2008;115:1134-1140.
68. Lam DS, Tham CC, Leung DY. Current approaches to the management of acute primary angle closure. Curr Opin Ophthalmol. 2007;18:146-151. Review.
69. Stilma JS, Boen-Tan TN. Timolol and intra-ocular pressure elevation following neodymium: YAG laser surgery. Doc Ophthalmol. 1986;61:2339.
70. Kumar N, Feyi-Waboso A. Intractable secondary glaucoma from hyphema following YAG iridotomy. Can J Ophthalmol. 2005;40:85-86.
71. Yuen NS, Cheung P, Hui SP. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their papillary effects following laser peripheral iridotomy. Jpn J Ophthalmol. 2005;48:89-92.
72. Chen TC. Brimonidine 0.15% versus apraclonidine 0.5% for the prevention of intraocular pressure elevation after anterior segment laser surgery. J Cataract Rfract Surg. 2005;31: 1707-1712.
73. Chevrier RL, Assalian A, Duperre J, et al. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. Ophthalmic Surg Lasers. 1999;30:199-204.
74. Lim LS, Husain R, Gazzard G, et al. Cataract progression after prophylactic laser peripheral iridotomy: potential implications for the prevention of glaucoma blindness. Ophthalmology. 2005;112:1355-1359.
75. Dhawahir-Scala FE, Clark D. Neodymium-YAG laser peripheral iridotomy: cause of visually significant incapacitating cataract. Ophthalmic Surg Lasers Imaging. 2006;37:330-332.
76. Lin JC, Katz LJ, Spaeth GL, et al. An "exploding cataract" following Nd: YAG laser iridectomy. Ophthalmic Surg Lasers Imaging. 2003;34:310-311.
77. Wishart PK, Sherrard ES, Nagasubramanian S, et al. Corneal endothelial changes following short pulsed laser iridotomy and surgical iridectomy.Trans Ophthalmol Soc UK. 1986;105: 541-548.
78. Schwartz AL, Martin NF, Weber PA. Corneal decompensation after argon laser iridectomy. Arch Ophthalmol. 1988;106: 1572-1574.
79. Lim LS, Ho CL, Ang LP, et al. Inferior corneal decompensation following laser peripheral iridotomy in the superior iris. Am J Ophthalmol. 2006;142:166-168.
80. Jeng S, Lee JS, Huang SC. Corneal decompensation after argon laser iridectomy-delayed complication. Ophthalmic Surg. 1991;22:565-569.
81. Murphy PH, Trope GE. Monocular blurring. A complication of YAG laser iridotomy. Ophthalmology. 1991;98:1539-1542.
82. Spaeth GL, Idowu O, Seligsohn A, et al. The effects of iridotomy size and position on symptoms following laser peripheral iridotomy. J Glaucoma. 2005;14:364-367.
83. He M, Huang W, Friedman DS, et al. Slit lamp-simulated oblique flashlight test in the detection of narrow angles in Chinese eyes: the Liwan eye study. Invest Ophthalmol Vis Sci. 2007;48:5459-5463.
84. Baskaran M, Oen FT, Chan YH, et al. Comparison of the scanning peripheral anterior chamber depth analyzer and the modified van Herick grading system in the assessment of angle closure. Ophthalmology. 2007;114:501-506.
85. Devereux JG, Foster PJ, Baasanhu J, et al. Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population. Arch Ophthalmol. 2000;118:257-263.
86. Barkana Y, Dorairaj SK, Gerber Y, et al. Agreement between gonioscopy and ultrasound biomicroscopy in detecting irido-trabecular apposition. Arch Ophthalmol. 2007;125:1331-1335.
87. Sakata LM, Lavanya R, Friedman DS, et al. Comparison of gonioscopy and anterior segment ocular coherence tomography in detecting angle closure in different quadrants of the anterior chamber angle. Ophthalmology. 2008;115:769-774.
88. Nolan WP, See JL, Chew PT, et al. Detection of primary angle closure using anterior segment optical coherence tomography in Asian eyes. Ophthalmology. 2007;114:33-39.
89. Burr JM, Mowatt G, Hernández R, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess. 2007;11:iii-iv, ix-x, 1-190.
90. Thomas R, Dogra M. An evaluation of medical college departments of ophthalmology in India and change following provision of modern instrumentation and training. Indian J Ophthalmol. 2008;56:9-16.
91. Janz NK, Wren PA, Lichter PR, et al; CIGTS Study Group. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954-1965.
92. Thomas R, Paul P, Rao GN, et al. Present status of eye care in India. Surv Ophthalmol. 2005;50:85-101.